Are individuals with lower neutrophil oxidative burst activity more prone to Helicobacter pylori infection?

Luminescence

Volumn 23, Issue 3, 2008, Pages 132-138

  Matsuzaka, Masashi ^a   Fukuda, Shinsaku ^a   Yamai, Kiyonori ^a   Tsuya, Ryousuke ^a   Fukuoka, Yu ^a   Takahashi, Ippei ^a   Yaegaki, Makoto ^a   Shimoyama, Tadashi ^a   Sakamoto, Juichi ^a   Umeda, Takashi ^a   Nakaji, Shigeyuki ^a  

^a HIROSAKI UNIVERSITY   (Japan)

Author keywords

Helicobacter pylori; Neutrophil; Oxidative burst activity; Peripheral blood

Indexed keywords

REGRESSION ANALYSIS;

GASTRIC MUCOSA; HEALTH PROMOTION; HELICOBACTER PYLORI; HELICOBACTER PYLORI INFECTIONS; NEUTROPHIL FUNCTIONS; NEUTROPHILE; OXIDATIVE BURST ACTIVITY; OXIDATIVE BURSTS; PERIPHERAL BLOOD; REACTIVE OXYGEN SPECIES;

BLOOD;

HELICOBACTER PYLORI;

EID: 46349104224     PISSN: 15227235     EISSN: 15227243     Source Type: Journal    
DOI: 10.1002/bio.1022     Document Type: Article

References (63)

1. Marshall BJ, Warren JR. Unidentified curved bacilli in the stomach of patients with gastritis and peptic ulceration. Lancet 1984; 1: 1311-1315.
2. Rothenbacher D, Brenner H. Burden of Helicobacter pylori and H. pylori-related diseases in developed countries: recent developments and future implications. Microbes Infect. 2003; 5: 693-703.
3. Dooley CP, Cohen H, Fitzgibbons PL, Bauer M, Appleman MD, Perez-Perez GI, Blaser MJ. Prevalence of Helicobacter pylori infection and histologie gastritis in asymptomatic persons. N. Engl. J. Med. 1989; 321: 1562-1566.
4. Goodwin CS, Armstrong JA, Marshall BJ. Campylobacter pyloridis, gastritis, and peptic ulceration. J. Clin. Pathol. 1986; 39: 353-365.
5. Yamaoka Y, Kita M, Kodama T, Sawai N, Kashima K, Imanishi J. Induction of various cytokines and development of severe mucosal inflammation by cagA gene-positive Helicobacter pylori strains. Gut 1997;41:442-451.
6. Yamaoka Y, Kita M, Kodama T, Sawai N, Imanishi J. Helicobacter pylori cagA gene and expression of cytokine messenger RNA in gastric mucosa. Gastroenterology 1996; 110: 1744-1752.
7. Suzuki H, Miura S, Imaeda H, Suzuki M, Han JY, Mori M, Fukumura D, Tsuchiya M, Ishii H. Enhanced levels of chemiluminescence and platelet activating factor in urease-positive gastric ulcers. Free Radic. Biol. Med. 1996; 20: 449-454.
8. Davies GR, Simmonds NJ, Stevens TR, Sheaff MT, Banatvala N, Laurenson IF, Blake DR, Rampton DS. Helicobacter pylori stimulates antral mucosal reactive oxygen metabolite production in vivo. Gut 1994; 35: 179-185.
9. Drake IM, Mapstone NP, Schorah CJ, White KL, Chalmers DM, Dixon MF, Axon AT. Reactive oxygen species activity and lipid peroxidation in Helicobacter pylori associated gastritis: relation to gastric mucosal ascorbic acid concentrations and effect of H. pylori eradication. Gut 1998; 42: 768-771.
10. Danese S, Cremonini F, Armuzzi A, Candelli M, Papa A, Ojetti V, Pastorelli A, Di Caro S, Zannoni G, De Sole P, Gasbarrini G, Gasbarrini A. Helicobacter pylori CagA-positive strains affect oxygen free radicals generation by gastric mucosa. Scand. J. Gastroenterol. 2001; 36: 247-250.
11. Naito Y, Yoshikawa T. Molecular and cellular mechanisms involved in Helicobacter pylori-induced inflammation and oxidative stress. Free Radic. Biol. Med. 2002; 33: 323-336.
12. Zhang QB, Nakashabendi IM, Mokhashi MS, Dawodu JB, Gemmell CG, Russell RI. Association of cytotoxin production and neutrophil activation by strains of Helicobacter pylori isolated from patients with peptic ulceration and chronic gastritis. Gut 1996; 38: 841-845.
13. Franchini M, Veneri D. Helicobacter pylori-associated immune thrombocytopenia. Platelets 2006; 17: 71-77.
14. Whincup P, Danesh J, Walker M, Lennon L, Thomson A, Appleby P, Hawkey C, Atherton J. Prospective study of potentially virulent strains of Helicobacter pylori and coronary heart disease in middle-aged men. Circulation 2000; 101: 1647-1652.
15. Franceschi F, Leo D, Fini L, Santoliquido A, Flore R, Tondi P, Roccarina D, Nista EC, Cazzato AI, Lupascu A, Pola P, Silveri NG, Gasbarrini G, Gasbarrini A. Helicobacter pylori infection and ischaemic heart disease: an overview of the general literature. Dig. Liver Dis. 2005; 37: 301-308.
16. Roussos A, Philippou N, Gourgoulianis KI. Helicobacter pylori infection and respiratory diseases: a review. World J. Gastroenterol. 2003; 9: 5-8.
17. Mayr M, Kiechl S, Mendall MA, Willeit J, Wick G, Xu Q. Increased risk of atherosclerosis is confined to CagA-positive Helicobacter pylori strains: prospective results from the Bruneck study. Stroke 2003; 34: 610-615.
18. Weller C, Charlett A, Oxlade NL, Dobbs SM, Dobbs RJ, Peterson DW, Bjarnason IT. Role of chronic infection and inflammation in the gastrointestinal tract in the etiology and pathogenesis of idiopathic parkinsonism. Part 3: predicted probability and gradients of severity of idiopathic parkinsonism based on H. pylori antibody profile. Helicobacter 2005; 10: 288-297.
19. Amedei A, Cappon A, Codolo G, Cabrelle A, Polenghi A, Benagiano M, Tasca E, Azzurri A, D'Elios MM, Del Prete G, de Bernard M. The neutrophil-activating protein of Helicobacter pylori promotes Th1 immune responses. J. Clin. Invest. 2006; 116: 1092-1101.
20. Nurgalieva ZZ, Conner ME, Opekun AR, Zheng CQ, Elliott SN, Ernst PB, Osato M, Estes MK, Graham DY. B-cell and T-cell immune responses to experimental Helicobacter pylori infection in humans. Infect. Immun. 2005; 73: 2999-3006.
21. Brenner H, Berg G, Frohlich M, Boeing H, Koenig W. Chronic infection with Helicobacter pylori does not provoke major systemic inflammation in healthy adults: results from a large population-based study. Atherosclerosis 1999; 147: 399-403.
22. Benestad HB, Laerum OD. The neutrophilic granulocyte. Curr. Top. Pathol. 1989; 79: 7-36.
23. Sawyer DW, Donowitz GR, Mandell GL Polymorphonuclear neutrophils: an effective antimicrobial force. Rev. Infect. Dis. 1989; 11 (suppl 7): S1532-1544.
24. Ehlenberger AG, Nussenzweig V. The role of membrane receptors for C3b and C3d in phagocytosis. J. Exp. Med. 1977; 145: 357-371.
25. Unkeless JC, Wright SD. Structure and modulation of Fc and complement receptors. Contemp. Top. Immunobiol. 1984; 14: 171-187.
26. Pyne DB. Regulation of neutrophil function during exercise. Sports Med. 1994; 17: 245-258.
27. Duarte JA, Appell HJ, Carvalho F, Bastos ML, Scares JM. Endothelium-derived oxidative stress may contribute to exercise-induced muscle damage. Int. J. Sports Med. 1993; 14: 440-443.
28. Mashimo M, Nishikawa M, Higuchi K, Hirose M, Wei Q, Haque A, Sasaki E, Shiba M, Tominaga K, Watanabe T, Fujiwara Y, Arakawa T, Inoue M. Production of reactive oxygen species in peripheral blood is increased in individuals with Helicobacter pylori infection and decreased after its eradication. Helicobacter 2006; 11: 266-2671.
29. Rioux N, Castonguay A. Recovery from 4-(methylnitrosamino)-1-(3-pyridyl)- 1-butanone-induced immunosuppression in A/J mice by treatment with nonsteroidal anti-inflammatory drugs. J. Natl Cancer Inst. 1997; 89: 874-880.
30. Tanaka K, Tanaka H, Kanemoto Y, Tsuboi I. The effects of nonsteroidal anti-inflammatory drugs on immune functions of human peripheral blood mononuclear cells. Immunopharmacology 1998; 40: 209-217.
31. Kosunen TU, Seppala K, Sarna S, Sipponen P. Diagnostic value of decreasing IgG, IgA, and IgM antibody titres after eradication of Helicobacter pylori. Lancet 1992; 339: 893-895.
32. Hed J. The extinction of fluorescence by crystal violet and its use to differentiate between attached and ingested micro-organisms in phagocytosis. FEBS Lett. 1977; 1: 357-361.
33. Sahlin S, Hed J, Rundquist I. Differentiation between attached and ingested immune complexes by a fluorescence quenching cytofluorometric assay. J. Immunol. Methods 1983; 60: 115-124.
34. Suzuki K, Sato H, Kikuchi T, Abe T, Nakaji S, Sugawara K, Totsuka M, Sato K, Yamaya K. Capacity of circulating neutrophils to produce reactive oxygen species after exhaustive exercise. J. Appl. Physiol. 1996; 81: 1213-1222.
35. Kikuchi T, Suzuki K, Abe T, Satoh H, Endoh T, Hasegawa H, Nakaji S, Sugawara K, Kumae T. Measurement of chemiluminescence from neutrophils in a 96-well microplate using Lumi Box U-800 II. J. Biolumin. Chemilumin. 1997; 12: 149-153.
36. Saito D, Nakaji S, Umeda T, Kurakake S, Danjo K, Shimoyama T, Sugawara K. Effects of long-distance running on serum opsonic activity measured by chemiluminescence. Luminescence 2003; 18: 122-124.
37. Kokot K, Schaefer RM, Teschner M, Gilge U, Plass R, Heidland A. Activation of leukocytes during prolonged physical exercise. Adv. Exp. Med. Biol. 1988; 240: 7-63.
38. Kumae T. A study of the fluorescence measurement using a 96-well microplate by a remodelled parallel luminescent measuring system. Luminescence 1999; 14: 375-381.
39. Giesecke J. International association between Helicobacter pylori and gastric cancer. Lancet 1993; 342: 120-121.
40. Perez-Perez GI, Rothenbacher D, Brenner H. Epidemiology of Helicobacter pylori infection. Helicobacter 2004; 9(suppl 1): 1-6.
41. Epidemiology of, and risk factors for, Helicobacter pylori infection among 3194 asymptomatic subjects in 17 populations. The EUROGAST Study Group. Gut 1993; 34: 1672-1676.
42. Murray U, McCrum EE, Evans AE, Bamford KB. Epidemiology of Helicobacter pylori infection among 4742 randomly selected subjects from Northern Ireland. Int. J. Epidemiol. 1997; 26: 880-887.
43. Moayyedi P, Axon AT, Feltbower R, Duffett S, Crocombe W, Braunholtz D, Richards ID, Dowell AC, Forman D. Relation of adult lifestyle and socioeconomic factors to the prevalence of Helicobacter pylori infection. Int. J. Epidemiol. 2002; 31: 624-631.
44. Graham DY, Malaty HM, Evans DG, Evans DJ, Jr., Klein PD, Adam E. Epidemiology of Helicobacter pylori in an asymptomatic population in the United States. Effect of age, race, and socioeconomic status. Gastroenterology 1991; 100: 1495-1501.
45. Woodward M, Morrison C, McColl K. An investigation into factors associated with Helicobacter pylori infection. J. Clin. Epidemiol. 2000; 53: 175-181.
46. Banatvala N, Mayo K, Megraud F, Jennings R, Deeks JJ, Feldman RA. The cohort effect and Helicobacter pylori. J. Infect. Dis. 1993; 168: 219-221.
47. Cardenas VM, Graham DY. Smoking and Helicobacter pylori infection in a sample of US adults. Epidemiology 2005; 16: 586-590.
48. Brenner H, Rothenbacher D, Bode G, Adler G. Relation of smoking and alcohol and coffee consumption to active Helicobacter pylori infection: cross sectional study. Br. Med. J. 1997; 315: 1489-1492.
49. Murray LJ, Lane AJ, Harvey IM, Donovan JL, Nair P, Harvey RF. Inverse relationship between alcohol consumption and active Helicobacter pylori infection: the Bristol Helicobacter project. Am. J. Gastroenterol. 2002; 97: 2750-2755.
50. Kuepper-Nybelen J, Thefeld W, Rothenbacher D, Brenner H. Patterns of alcohol consumption and Helicobacter pylori infection: results of a population-based study from Germany among 6545 adults. Aliment. Pharmacol. Ther. 2005; 21: 57-64.
51. Brenner H, Bode G, Adler G, Hoffmeister A, Koenig W, Rothenbacher D. Alcohol as a gastric disinfectant? The complex relationship between alcohol consumption and current Helicobacter pylori infection. Epidemiology 2001; 12: 209-214.
52. Karttunen TJ, Niemela S, Kerola T. Blood leukocyte differential in Helicobacter pylori infection. Dig. Dis. Sci. 1996; 41: 1332-1336.
53. Graham DY, Malaty HM, Evans DG, Evans DJ Jr, Klein PD, Adam E. Epidemiology of Helicobacter pylori in an asymptomatic population in the United States. Effect of age, race, and socioeconomic status. Gastroenterology 1991; 100: 1495-1501.
54. Kondo Y, Joh T, Sasaki M, Oshima T, Itoh K, Tanida S, Kataoka H, Ohara H, Nomura T, Itoh M. Helicobacter pylori eradication decreases blood neutrophil and monocyte counts. Aliment Phormocol Ther 2004; 20(supp 1): 74-79.
55. Megraud F, Lamouliatte H. Review article: the treatment of refractory Helicobacter pylori infection. Aliment. Pharmacol. Ther. 2003; 17: 1333-1343.
56. Takahashi I, Umeda T, Mashiko T, Chinda D, Oyama T, Sugawara K, Nakaji S. Effects of rugby sevens matches on human neutrophil-related non-specific immunity. Br. J. Sports Med. 2007; 41: 13-18.
57. Mochida N, Umeda T, Yamamoto Y, Tanabe M, Kojima A, Sugawara K, Nakaji S. The main neutrophil and neutrophil-related functions may compensate for each other following exercise - a finding from training in university judoists. Luminescence 2007; 22: 20-28.
58. Suzuki M, Nakaji S, Umeda T, Shimoyama T, Mochida N, Kojima A, Mashiko T, Sugawara K. Effects of weight reduction on neutrophil phagocytic activity and oxidative burst activity in female judoists. Luminescence 2003; 18: 214-217.
59. Miura M, Umeda T, Nakaji S, Liu Q, Tanabe M, Kojima A, Yamamoto Y, Sugawara K. Effect of 6 months' training on the reactive oxygen species production capacity of neutrophils and serum opsonic activity in judoists. Luminescence 2005; 20: 1-7.
60. Suzuki M, Umeda T, Nakaji S, Shimoyama T, Mashiko T, Sugawara K. Effect of incorporating low intensity exercise into the recovery period after a rugby match. Br. J. Sports Med. 2004; 38: 436-440.
61. Chinda D, Nakaji S, Umeda T, Shimoyama T, Kurakake S, Okamura N, Kumae T, Sugawara K. A competitive marathon race decreases neutrophil functions in athletes. Luminescence 2003; 18: 324-329.
62. Chinda D, Umeda T, Shimoyama T, Kojima A, Tanabe M, Nakaji S, Sugawara K. The acute response of neutrophil function to a bout of judo training. Luminescence 2003; 18: 278-282.
63. Yaegaki M, Umeda T, Takahashi I, Matsuzaka M, Sugawara N, Shimaya S, Tanabe M, Kojima A, Mochida N, Yamamoto Y, Nakaji S. Change in the capability of reactive oxygen species production by neutrophils following weight reduction in female judoists. Br. J. Sports Med. 2007; 41: 322-327.